drugset / Trial / NCT03524339

Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery

NCT03524339 ↗

Phase 2/3 Completed 132 enrolled University Hospitals Cleveland Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a placebo controlled randomized controlled trial of perioperative use of tamsulosin to prevent postoperative urinary retention in female pelvic reconstructive surgery.

Timeline

Start
2018-08-01
Primary completion
2020-06-09
Completion
2020-06-09

Outcome

Met primary endpoint

paper Tamsulosin was associated with a lower rate of postoperative urinary retention than placebo (5 patients [8.8%] vs 16 patients [25.8%]; PMID 33894146 ↗

paper odds ratio, 0.28; 95% confidence interval, 0.09-81; P=.02). PMID 33894146 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tamsulosin Other / unclassified 0.4 mg —